Skip to main content
. 2012 May 16;26(7):1129–1143. doi: 10.1210/me.2011-1341

Fig. 6.

Fig. 6.

A model for the steroidogenic pathway through SF-1-mediated transcription of miR-383 in GC. Transactivation of miR-383 by SF-1 inhibits the expression of RBMS1 and its downstream c-Myc, and subsequently promotes E2 release in GC.